Ïã¸ÛÁùºÏ²Ê

XClose

Precision Medicine

Home
Menu

Target Discoveries and Biomarkers

Discovery of targeted and personalised interventions.

Target discovery involves the identification and early validation of disease-modifying targets. Biomarkers play an important role in this process as they can be used to indicate disease progression and assess the outcome.

The Institute aims to link genetics, genomics, cell and chemical biology for improved drug target discovery.

Ïã¸ÛÁùºÏ²Ê Drug Discovery Group

°Õ³ó±ðÌýÏã¸ÛÁùºÏ²Ê Translational Research Office (TRO), in partnership with the Ïã¸ÛÁùºÏ²Ê School of Pharmacy, has established the Ïã¸ÛÁùºÏ²Ê Drug Discovery Group - a core medicinal chemistry facility. Populated by experienced, industry-background medicinal chemists, the group is based in the Ïã¸ÛÁùºÏ²Ê School of Pharmacy's established laboratories.

Omics

Ïã¸ÛÁùºÏ²Ê has a number of groups that are involved in omics studies (genomics, proteomics, metabolomics, lipidomics, glycomics) and how these might be applied in clinical practice.

Ïã¸ÛÁùºÏ²ÊÌýMedical GenomicsÌýLaboratory
The Ïã¸ÛÁùºÏ²Ê Medical Genomics Laboratory has broad interests in the genomics and epigenomics of phenotypic plasticity in health and disease. In addition to genetic variations, the laboratory studies epigenetic variations such as DNA methylation, histone modifications and microRNAs and how they modulate genome function.Ìý

Ïã¸ÛÁùºÏ²Ê Centre for Translational Omics
The Ïã¸ÛÁùºÏ²ÊÌýCentre for Translational Omics bringsÌýtogether a group of experts in developing and applying omics (genomics, proteomics, metabolomics, lipidomics, glycomics) technologies.Ìý